MoonLake Immunotherapeutics Completes Patient Enrollment, Randomization Ahead Of Phase 2 Trial Of Nanobody Sonelokimab

Feb 2 (Reuters) - MoonLake Immunotherapeutics: * MOONLAKE IMMUNOTHERAPEUTICS COMPLETES PATIENT ENROLLMENT AND RANDOMIZATION AHEAD OF SCHEDULE IN A PHASE 2 TRIAL OF THE NANOBODY® SONELOKIMAB IN

ADC Therapeutics Announces Pricing Of Underwritten Offering

Feb 2 (Reuters) - ADC Therapeutics SA: * ADC THERAPEUTICS ANNOUNCES PRICING OF UNDERWRITTEN OFFERING BY A SELLING SHAREHOLDER * ADC THERAPEUTICS - PRICING OF UNDERWRITTEN OFFERING OF 12 MILLION COMMON

Draft WHO pandemic deal pushes for equity to avoid COVID 'failure' repeat

(Adds WHO comment) By Jennifer Rigby and Gabrielle Tétrault-Farber LONDON/GENEVA, Feb 1 (Reuters) - Governments may have to reserve drugs and vaccines for the World Health Organization to distribute

European shares muted on caution ahead of Fed rate decision

(For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window) * STOXX 600 flat * Euro zone manufacturing downturn eases * Husqvarna climbs on Q4 sales

Draft WHO pandemic deal pushes for equity to avoid COVID 'failure' 

By Jennifer Rigby and Gabrielle Tétrault-Farber LONDON/GENEVA, Feb 1 (Reuters) - Governments may have to reserve drugs and vaccines for the World Health Organization to distribute in poorer countries

MIDEAST STOCKS-Dubai leads Gulf markets higher; Qatar ends lower

Feb 1 (Reuters) - Dubai stock market closed higher on Wednesday, outperforming the Gulf region, while Qatari stocks retreated amid volatile energy prices. Dubai's benchmark index snapped its losing

New Silkroutes Says Proposed Disposal Of Dental Clinics By Indirect Units

Feb 1 (Reuters) - New Silkroutes: * PROPOSED DISPOSAL OF DENTAL CLINICS BY INDIRECT UNITS OF COMPANY * CO AND SHAREHOLDERS ENTERED INTO BUSINESS TRANSFER AGREEMENT WITH DENTAL HUB IN RELATION TO SALE

Novartis says China still a big growth market as state widens drug availability

BASEL, Feb 1 (Reuters) - Swiss pharmaceutics maker Novartis said on Wednesday China remains a large growth opportunity despite a drop in its population, as the government spurs efforts to make

Virogates Appoints Josephine Baum Jørgensen As New CFO

Feb 1 (Reuters) - ViroGates A/S: * APPOINTS JOSEPHINE BAUM JØRGENSEN AS ITS NEW CFO * JOSEPHINE BAUM JØRGENSEN WILL BE JOINING VIROGATES AS CO'S NEW CFO SUCCEEDING MARK DA SILVA * JOSEPHINE WILL JOIN

Greenlight Biosciences Receives Approval To Initiate Phase I/II Clinical Trial Of Covid-19 mRNA Vaccine Candidate

Feb 1 (Reuters) - Greenlight Biosciences Holdings PBC : * GREENLIGHT BIOSCIENCES RECEIVES APPROVAL TO INITIATE PHASE I/II CLINICAL TRIAL OF COVID-19 MRNA VACCINE CANDIDATE * GREENLIGHT BIOSCIENCES